Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Affer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
NPJ Precision Oncology|October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Cell Reports|July 25, 2019
Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune DiseaseAlice Cho, Amber L Caldara, Nina A Ran, et al.
Leukemia|July 12, 2024
Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibitionSana Chaudhry, Felipe Beckedorff, Shaista Shabbir Jasdanwala, et al.
Cancer Research|June 18, 2025
XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome ChemoresistanceTulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca, et al.
Blood|January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signaturesBenjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Rapid generation of neutralizing antibody responses in COVID-19 patientsMehul S Suthar, Matthew Zimmerman, Robert Kauffman, et al.
Cell Reports. Medicine|August 25, 2020
Rapid Generation of Neutralizing Antibody Responses in COVID-19 PatientsMehul S Suthar, Matthew G Zimmerman, Robert C Kauffman, et al.
Science (New York, N.Y.)|February 1, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127Skye Montoya, Jessie Bourcier, Mark Noviski, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
NPJ Precision Oncology|October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Cell Reports|July 25, 2019
Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune DiseaseAlice Cho, Amber L Caldara, Nina A Ran, et al.
Leukemia|July 12, 2024
Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibitionSana Chaudhry, Felipe Beckedorff, Shaista Shabbir Jasdanwala, et al.
Cancer Research|June 18, 2025
XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome ChemoresistanceTulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca, et al.
Blood|January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signaturesBenjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Rapid generation of neutralizing antibody responses in COVID-19 patientsMehul S Suthar, Matthew Zimmerman, Robert Kauffman, et al.
Cell Reports. Medicine|August 25, 2020
Rapid Generation of Neutralizing Antibody Responses in COVID-19 PatientsMehul S Suthar, Matthew G Zimmerman, Robert C Kauffman, et al.
Science (New York, N.Y.)|February 1, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127Skye Montoya, Jessie Bourcier, Mark Noviski, et al.
Pageof 2